On 27 October, Melbourne IP barrister Campbell Thompson will discuss the recent decisions in the High Court of Australia in D’Arcy v Myriad Genetics Inc [2015] HCA 35 (7 October 2015) and AstraZeneca AB v Apotex Pty Ltd [2015] HCA 30 (2 September 2015), and some of their possible practical implications.
For Attorneys
For the community
For Media & Policy Makers
Level 15, 1 Nicholson Street
Melbourne, VIC 3000